NASDAQ:OCUL

Ocular Therapeutix Stock Forecast

etoro logo Buy OCUL
*Your capital is at risk
$8.70
-0.0400 (-0.458%)
At Close: Jun 11, 2026
AI Analysis AI Analysis of OCUL AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OCUL to Watchlist?
Some Reasons Why To Add OCUL:
  • High gross margin of 87.2%
  • Low bankruptcy risk (Altman Z-Score: 5.09)
  • Highly efficient cash conversion (107% FCF/OCF ratio)
PDF

Weaker technical forecast for Ocular Therapeutix as stock downgraded to Sell Candidate
(Updated on Jun 11, 2026)

Sell candidate since Jun 11, 2026

The Ocular Therapeutix stock price fell by -0.458% on the last day (Thursday, 11th Jun 2026) from $8.74 to $8.70. During the last trading day the stock fluctuated 3.56% from a day low at $8.57 to a day high of $8.88. The price has fallen in 6 of the last 10 days and is down by -4.92% for this period. Volume has increased on the last day by 97 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $24.03 million.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.31% during the next 3 months and, with a 90% probability hold a price between $7.91 and $10.34 at the end of this 3-month period.

OCUL Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 8.89%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ocular Therapeutix stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $8.95. On a fall, the stock will find some support from the short-term average at $8.50. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Ocular Therapeutix stock

Ocular Therapeutix finds support from accumulated volume at $8.49 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.305 between high and low, or 3.56%. For the last week, the stock has had daily average volatility of 5.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OCUL) For The Upcoming Trading Day Of Friday 12th

For the upcoming trading day on Friday, 12th we expect Ocular Therapeutix to open at $8.72, and during the day (based on 14 day Average True Range), to move between $8.47 and $8.93, which gives a possible trading interval of +/-$0.460 (+/-5.43%) up or down from last closing price. If Ocular Therapeutix takes out the full calculated possible swing range there will be an estimated 5.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $8.76 (0.69%) than the support at $8.49 (2.41%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ocular Therapeutix stock A Buy?

Ocular Therapeutix holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.269 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 12, 2026 - $8.72 ( 0.172%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OCUL Performance

Trading levels for OCUL

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 9.02 3.68%
R2 8.90 2.34%
R1 8.83 1.51%
Price 8.70
S1 8.60 -1.17%
S2 8.53 -1.99%
S3 8.41 -3.33%

Accumulated Volume Support & Resistance Levels

Level Price
R3 9.71 11.61%
R2 9.16 5.29%
R1 8.76 0.690%
Price 8.70
S1 8.49 -2.41%
S2 8.47 -2.64%
S3 8.10 -6.90%

FAQ

What is the symbol for Ocular Therapeutix Stock and on which exchange is it traded?
The symbol for Ocular Therapeutix is OCUL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ocular Therapeutix Stock?
Ocular Therapeutix holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

How to buy Ocular Therapeutix Stock?
Ocular Therapeutix Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ocular Therapeutix Stock.

What's the current price of Ocular Therapeutix Stock?
As of the end of day on the Jun 11, 2026, the price of an Ocular Therapeutix (OCUL) share was $8.70.

What is the 52-week high and low for Ocular Therapeutix Stock?
The 52-week high for Ocular Therapeutix Stock is $16.42 and the 52-week low is $6.23.

What is the market capitalization of Ocular Therapeutix Stock?
As of the Jun 11, 2026, the market capitalization of Ocular Therapeutix is 1.905B.

When is the next earnings date for Ocular Therapeutix?
The upcoming earnings date for Ocular Therapeutix is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT OCULAR THERAPEUTIX
Ocular Therapeutix
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery; and DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammati...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
13.01% Jun 05
TPR
$140.47
3.50% Jun 04
GLBE
$31.61
5.09% May 05
FIZZ
$34.11
8.36% May 01
W
WCLD
$27.34
12.18% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE